Inogen Inc (INGN) is a publicly traded Healthcare sector company. As of May 21, 2026, INGN trades at $6.07 with a market cap of $170.57M and a P/E ratio of -6.88. INGN moved -1.71% today. Year to date, INGN is -4.66%; over the trailing twelve months it is +1.12%. Its 52-week range spans $5.34 to $12.91. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces INGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent INGN insider activity includes Bourque Michael J. bought 3.00K, Smith Kevin Raymond Merrill bought 11.71K, and Somer Jason sold 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $6.07 |
| Market Cap | $170.57M |
| P/E Ratio | -6.88 |
| EPS | $-0.92 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.91 |
| 52-Week Low | $5.34 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $351.50M |
| Net Income | $-24.90M |
| Gross Margin | 44.31% |
2 analysts cover INGN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.